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Abstract
Background: Research about the relationship between premenstrual syndrome (PMS) and major depression is
limited. This study examined the relationship between moderate to severe PMS and major depression in a
population-based sample of women of reproductive age. The objectives of the study were to assess the
association between premenstrual syndrome and major depression, to analyse how PMS and major depression
differ and to characterise the group of women who report both PMS and major depression.
Methods: Data were obtained from the Swiss Health Survey 2007. Included in the analysis was data from women
under the age of 55 without hysterectomy and who answered the questions on PMS symptoms. The population-
based sample consisted of 3518 women. Weighted prevalence rates were calculated and relative risk ratios for
PMS, major depression and women who reported both PMS and major depression, were calculated with logistic
multinominal logit regression.
Results: The prevalence of major depression was 11.3% in women screening positive for moderate PMS and 24.6%
in women screening positive for severe PMS. Compared to women without any of these conditions, women who
reported moderate to severe alcohol consumption had a lower risk for PMS. Women reporting use of
antidepressants, and use of oral contraceptives had a higher risk for major depression compared to women
without any of these conditions. Women reporting work dissatisfaction had a higher risk for PMS. A higher relative
risk to report both PMS and major depression compared to women without PMS or major depression was related
to factors such as high psychological distress, low mastery, psychotropic drug consumption, and low self-rated
health.
Conclusions: The results suggested that women who suffer from both PMS and major depression are more
impaired compared to women with only one disorder. The results further indicated that PMS and major depression
are different disorders that can, however, co-occur.
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Background
Premenstrual syndrome (PMS) and premenstrual dys-
phoric disorders (PMDD), as a severe form of pre-
menstrual syndrome, have shown to be associated with
several psychological conditions, such as reduced psy-
chological wellbeing [1-6], mood disorders, particularly
depressive disorders [7-14], and exacerbation of
depression [15]. There is limited research on the rela-
tionship between major depression and premenstrual
symptoms from studies with large sample sizes or from
population-based studies. Wittchen et al. [16] have indi-
cated a high comorbidity between PMDD and other
mood disorders (22.9%) in a community-based study.
Similar comorbidity rates were observed for PMS and
major depression by Yonkers et al. [9]. In a U.S. popula-
tion-based study, it was shown that women with men-
strual problems were significantly more likely to report
depression [17].
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depression has been investigated in several studies yield-
ing conflicting results. Some studies have shown that
women with PMS or PMDD have a higher percentage
of past major depression than women without PMS or
PMDD [10,11,18], while Hurt et al. have reported con-
tradictory results [19]: Although the risk of late luteal
phase dysphoric disorder (LLPDD) (the former term for
PMDD in the DSM-III-R) was 14% higher in women
with a past psychological disorder, it was not increased
in women who reported to suffer from a major depres-
sion in the past [19]. Breaux, Hartlage and Gehlert [20]
concluded in their review that based on existing
research it has not been fully proven whether women
with PMDD have a higher likelihood to report past
major depression.
T h e r ei sa l s os o m ee v i d e n c et h a tw o m e nw i t hP M D D
might be at a higher risk to develop major depression in
the future than women without PMDD [20,21].
Besides investigating the relationship between the two
disorders, examination of whether and how the two dis-
orders can be differentiated from each other is also of
relevance. For PMDD, the criteria of the DSM-IV
require the disturbance not to be merely an exacerba-
tion of the symptoms of another disorder, such as major
depression. Nevertheless, a clear distinction between
PMDD and depression seems not always as clear as
wished, and some symptoms, such as depressed mood,
feelings of hopelessness, decreased interest in usual
activities, concentration difficulties, lack of energy,
change in appetite, hypersomnia or insomnia are
included in measures for both disorders [22,23]. Some
authors described an overlap of symptoms such as irrit-
ability, or mood swings between severe premenstrual
syndrome and depression [24]. Others, however, empha-
sised that despite the intriguing similarities between
PMDD and depression, they should be regarded as dis-
tinct diagnostic entities [25]. Irritability has been
described as a more prominent symptom in women
with PMS or PMDD than depressed mood [12,26]. Dif-
ferences in the dysregulation in the stress axes in
women with PMDD and in women with current or past
depressive disorders also suggest the two disorders to be
distinct [27]. Results of studies about risk factors for
depression or PMS suggested that the two disorders
might have differing causes. In a longitudinal popula-
tion-based twin study, it was suggested that genetic and
environmental risk factors of premenstrual symptoms
and major depression are not closely associated [28].
Premenstrual symptoms seem to be only to a small
degree or not at all influenced by familial-environmental
factors [28].
To our knowledge, little is known about the group of
women who report both major depression and
premenstrual symptoms. Comorbidity could be related
to higher impairment which would make appropriate
treatment for this group of women particularly relevant.
Soares et al. [29] have shown that women with PMDD
and a history of depression were less educated and
reported marital disruption less frequently than women
with PMDD and no history of depression.
T h e r ei sap a u c i t yo fd a t af r o mp o p u l a t i o n - b a s e ds t u -
dies on the association between and the distinction of
PMS and major depression, and especially knowledge
about the group of women reporting to suffer from both
is also limited. The first aim of this study was therefore
to assess the prevalence of women reporting both major
depression and premenstrual symptoms in a large popu-
lation-based sample and to analyse how women with
PMS and depression differ from each other. A second
aim was to characterise women who report both major
depression and premenstrual symptoms.
Methods
Recruitment and Participants
Data presented in this study was assessed for the nation-
wide Swiss Health Survey 2007 (SHS), which is con-
ducted every five years since 1992 as a cross-sectional
study by the Swiss Federal Office of Statistics. The SHS
aims to give information about health status, health
related behaviors, prevalence and consequences of dis-
eases, and health care utilization. The data of the SHS
are available from the Swiss Federal Office of Statistics
upon request. For this study, a permission to analyse the
data was obtained (Contract Number 30.23-2008). For
the SHS 2007, a random sample of adults living in Swit-
zerland aged 15 years or older was drawn. The assess-
ment consisted of two parts, a telephone interview and
an additional written questionnaire. The response rate
for the telephone interview was 66% (18760). The writ-
ten questionnaire was sent to all participants of the tele-
phone interview. It was completed by 80% of the
participants who had taken part in the telephone inter-
view (14,432). The questions about premenstrual symp-
toms were included in the written part of the
questionnaire.
The sample for this study was restricted to women
under the age of 55 with no history of hysterectomy and
who answered the questions on PMS symptoms (N =
3522). Mean age was 35.46 years.
Assessment of premenstrual syndrome
To assess premenstrual symptoms and to differentiate
between women with or without moderate to severe
PMS, a slightly modified version of the premenstrual
symptoms screening tool (PSST) [22] was used. The
modified PSST version used in this study consists of 10
items (instead of originally 14 items) each describing a
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a 4-point Likert scale. The PSST is based on the DSM-
IV criteria of PMDD. A German translation of the PSST
was used for this study. A German version of the PSST
by Bentz, Steiner and Meinlschmidt [30] has recently
been shown to be a reliable and valid measure for the
screening of premenstrual symptoms. Due to restrictions
with regard to the number of items that could be
included in the Swiss Health Survey, three of the PMS
questions were dropped (decreased interest in work
activities, home activities and social activities) or merged
into one question (insomnia and hypersomnia). The two
questions on interference of symptoms with relation-
ships with co-workers and with family were also merged
together. To determine severe PMS, the instructions of
the premenstrual symptoms screening tool of Steiner et
al. [22] were used as followed: For severe PMS, at least
one of the main symptoms (anger or irritability, anxiety
or tension, tearfulness or mood swings, depressed
mood) had to be severe, at least four of the additional
symptoms had to be moderate to severe and one of the
interferences (work efficiency, relationships with co-
workers or family, social life activities, and home
responsibilities) had to be severe [22]. For moderate
PMS, at least one of the four main symptoms had to be
moderate to severe, at least four of the additional symp-
toms had to be moderate to severe and one of the inter-
ferences had to be moderate to severe.
Assessment of major depression
Major depression was assessed with the World Health
Organization’s Composite International Diagnostic
Interview Short Form (CIDI-SF) [23]. The CIDI-SF is a
brief and reliable screening measure that has been vali-
dated by Kessler and colleagues [23] and allows generat-
ing DSM-IV diagnoses. To calculate a score, 23 of the
35 items of the interview were used. The score was
based on reported type and length of symptoms.
Statistical Analyses
Chi-square tests and multinominal logit regression were
conducted using STATA 10 to compare the four groups:
women without major depression or PMS, women with
major depression only, women with PMS only and
women with both major depression and PMS. The statis-
tical analyses were considered to be significant with p <
0.05. For the chi-square tests weighted dated was used.
Results
Characteristics of the sample
Table 1 shows sociodemographic characteristics of the
total sample and of the four groups (women without
PMS and depression, women with PMS, women with
major depression, women with both PMS and
depression). No significant differences between the four
groups were found in age, but were present in marital
status and living arrangements, with the highest propor-
tions of being unmarried and separated/divorced, living
alone, and being a single parent in women with major
depression. Of the overall sample, 7.2% had a major
depression, 10.3% moderate PMS and 3.2% severe PMS.
Relationship and differences in women with PMS and
major depression
Table 2 shows that 11.3% of women with moderate PMS
and 24.6% of women with severe PMS suffered addition-
ally from major depression compared to 6.2% of the
women who did not report PMS. Current treatment for
depression was reported by 3.4% of the women with
moderate PMS and 15.1% of the women with severe
PMS compared to 2.4% of women without PMS. Daily
consumption of antidepressants was highest in women
with severe PMS (23.4%) and lowest in women without
PMS (5.8%). The highest percentage of women taking
tranquilizers or sleeping pills was in women with moder-
ate PMS (16.0%). Of the women with severe PMS, 35%
reported to take any type of psychotropic medication.
Differences in health status and health behaviour
between the four groups (women without major depres-
sion or PMS, women with PMS, women with major
depression, women with major depression plus PMS)
are shown in Table 3. They were found to be significant
for most of the health status variables. The highest per-
centage of women taking oral contraception was in the
group of women who reported suffering from major
depression (37.9%). A significant difference between the
four groups was also found in alcohol consumption (p =
.006) with 9.2% of women with major depression report-
ing moderate to severe consumption compared to 3.6%
of the women without any of the two disorders. Signifi-
cant differences were also found in psychotropic drug
consumption (p = .000), work satisfaction (p = .0009),
mastery (p = .000), self-rated health (p = .000), sleeping
difficulties (p = .000) and psychological distress (p =
.000). Among the four groups, consumption of antide-
pressants only was highest in women with major depres-
sion only (12.4%). In contrary, consumption of sleeping
pills/tranquillizers and antidepressants was highest in
women with both conditions, PMS and major depres-
sion (35.8%). Of the women with both conditions, 74.4%
reported low mastery, 25.8% poor self-rated health,
33.5% high psychological distress, 33.6% strongly agreed
to sleeping difficulties, and 27.1% reported to be partly
satisfied to extremely dissatisfied with work.
Predictors for PMS and/or major depression
Table 4 shows the results of the multinominal logit
regression. Relative risk ratios (RRR) were calculated to
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Page 3 of 11Table 1 Socio-demographic characteristics in women without and with PMS, major depression, and with PMS plus
depression (weighted prevalence rates)
No PMS or depression PMS Only Major depression only PMS plus depression Total c
2
(n = 2848) (n = 413) (n = 197) (n = 60) (n = 3518) (df)
%%% %%
Age (years)
14-25 23.7 24.4 23.1 24.1 23.8
24-35 27.5 21.2 28.2 24.4 26.7
34-45 31.8 37.4 30.0 23.4 32.2
44-55 17.0 17.0 18.8 28.1 17.3
Total 100 100 100 100 100 9.13 (9)
Marital status
Unmarried 41.8 43.3 46.1 42.2 42.2
Married 50.6 47.5 41.5 50.0 49.7
Widowed 0.6 1.3 0.7 0.0 0.7
Separated/Divorced 7.0 7.9 11.8 7.9 7.3
Total 100 100 100 100 100 18.95* (9)
Language regions
German-speaking 71.3 63.6 71.6 52.5 70.1
French-speaking 24.4 30.2 24.4 39.8 25.4
Italian-speaking 4.2 6.2 4.0 7.8 4.5
Total 100 100 100 100 100 10.56 (6)
Nationality
Swiss 75.9 70.5 75.0 58.7 74.9
Other 24.1 29.5 25.0 41.3 25.1
Total 100 100 100 100 100 4.43 (3)
Profession
Higher-middle management 42.5 38.6 39.5 29.6 41.7
Office worker 31.9 39.4 29.1 23.2 32.4
Craftsperson 5.5 4.9 6.8 9.7 5.5
Labourer 20.1 17.2 24.6 37.5 20.3
Total 100 100 100 100 100 9.39 (9)
Education
Compulsory school 9.3 9.0 8.0 25.8 9.5
Secondary school 65.3 66 69.7 59.6 65.5
College/university 25.4 25 22.4 14.6 25
Total 100 100 100 100 100 5.86 (6)
Employment
Full time 30.1 26.6 29.0 21.6 29.4
Part time 45.4 41.1 49.2 39.8 45
No employment 24.5 32.3 21.8 38.5 25.5
Total 100 100 100 100 100 7.77 (6)
Living arrangements
Living alone 8.8 10.0 17.0 10.1 9.4
Couple without child 18.9 14.9 16.5 18.7 18.3
Couple with child 62 63.5 49.4 62.3 61.5
Single parent 8.5 9.7 16.2 7.4 9
Other 1.8 1.9 0.8 1.6 1.8
Total 100 100 100 100 100 21.78* (12)
*p < .05
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sion or PMS, women with PMS, women with major
depression, and women with both conditions) with
women without major depression or PMS as reference
group. Language region (Italian-speaking) and education
were the only socio-demographic factors significantly
associated with one of the four groups: women from the
Italian-speaking part had a higher risk of reporting PMS
than the reference group (RRR 1.84, p < .01). Women
with a secondary school (RRR 3.83, p < .05) or a univer-
sity/college degree (RRR 3.72, p < .05) also had a higher
likelihood of reporting PMS than women of the refer-
ence group.
Women taking oral contraception were at higher risk
of suffering from major depression than women with
none of the two conditions (reference group) (RRR 1.67,
p < .05). Women who reported taking antidepressants
were more likely to suffer from depression (RRR 3.16, p
< .01) and from depression and PMS (RRR 5.38, p <
.05). The consumption of both tranquillizers/sleeping
pills and antidepressants, was more likely in women
with depression and PMS (RRR 5.18, p < .05). Women
who reported having moderate to severe alcohol con-
sumption were at lower risk of screening positive for
PMS than the reference group (RRR 0.34, p < .05). Dif-
fering associations in alcohol consumption were found
for women with PMS (RRR below 1) and women with
major depression (RRR above 1).
Women with medium or high psychological distress
showed a higher risk of suffering from major depression
(medium distress: RRR 1.68, p < .05; high distress: RRR
3.32, p < .01) and an even higher risk of suffering from
PMS plus major depression (high distress: RRR 7.97, p <
.001) than women of the reference group. High mastery
and good self-rated health were protective factors.
Women who reported high mastery had a lower risk of
screening positive for PMS (RRR 0.39, p < .001), from
major depression (RRR 0.34, p < .001) and from both
Table 2 Frequencies of major depression, treatment for depression, treatment for psychological problems, consumption
of psychotropic medication, and antidepressants in women with and without PMS (weighted prevalence rates)
No PMS
(n = 3045)
Moderate PMS
(n = 363)
Severe PMDD
(n = 110)
Total
(n = 3518)
c
2 (df)
%% % %
Major Depression
Major Depression 6.2 11.3 24.6 7.3
No Major Depression 93.8 88.7 75.4 92.7
Total 100 100 100 100 11.58** (2)
Treatment for Depression
No 92.1 84.5 73.6 90.8
Yes, before the last 12 months 3.6 7.9 6.2 4.1
Yes, within the last 12 months 1.9 4.2 5.2 2.2
In treatment at the moment 2.4 3.4 15.1 2.9
Total 100 100 100 100 18.02** (6)
Consumption antidepressants
Daily 5.8 9.7 23.4 7.0
Once to Several times per week 0.5 0.6 8.1 0.9
Never 93.7 89.7 68.5 92.1
Total 100 100 100 100 6.77 (4)
Treatment psychological problems in the last 12 months
Yes 5.7 12.5 19.7 6.8
No 94.3 87.5 80.3 93.2
Total 100 100 100 100 14.81*** (2)
Consumption of psychotropic medication
None 88.8 73.7 65.0 85.9
Antidepressants only 3.7 5.4 6.9 4.0
Tranquilizers/sleeping pills only 4.9 16.0 3.5 6.2
Tranquilizers/sleeping pills and antidepressants 2.6 4.9 24.6 3.8
Total 100 100 100 100 17.50** (6)
*p < .05; **p < .01; ***p < .001
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Page 5 of 11Table 3 Health status and health behavior in women without and with PMS, major depression, and with PMS plus
major depression (weighted prevalence rates)
No PMS or depression
(n = 2848)
PMS only
(n = 413)
Major depression only
(n = 197)
PMS plus depression
(n = 60)
Total
(n = 3518)
c
2 (df)
%%% % %
Body weight
Underweight 6.9 6.9 9.7 7.8 7.0
Normal weight 74.5 72.8 69.2 71.8 74
Overweight 13.5 13.3 12.3 9 13.3
Obese 5.1 7.0 8.8 11.4 5.6
Total 100 100 100 100 100 4.85 (9)
Pill as oral contraception
No 68 78.4 62.1 65.4 68.8
Yes 32 21.6 37.9 34.6 31.2
Total 100 100 100 100 100 9.85* (3)
Alcohol consumption
No consumption 33.5 35.1 19 40.5 33
Mild consumption 62.9 62.4 71.8 53.9 63.2
Moderate to severe
consumption
3.6 2.6 9.2 5.6 3.8
Total 100 100 100 100 100 17.99**
(6)
Smoking status
None smoker 59.1 51.1 47.3 50.4 57.4
Former smoker 15.3 22 17.9 18.5 16.3
Current smoker 25.6 26.9 34.8 31.1 26.3
Total 100 100 100 100 100 12.53 (6)
Cannabis consumption
Yes 2.5 2.7 6.2 7.4 2.8
No 97.5 97.3 93.8 92.6 97.2
Total 100 100 100 100 100 4.11 (3)
Health orientation
Not health oriented 9.7 9.6 17 9.6 10.1
Health oriented 90.3 90.4 83 90.4 89.9
Total 100 100 100 100 100 4.06 (3)
Psychotropic drug
consumption
None 90.9 78.2 67.3 42.6 86
Antidepressants only 2.9 4.9 12.4 9.7 4
Tranquillizer/sleeping pills only 4.6 13.1 7.5 11.9 6.2
Tranquillizer/sleeping pills and
antidepressants
1.5 3.8 12.7 35.8 3.7
Total 100 100 100 100 100 38.99***
(9)
Work satisfaction
Extremely satisfied 23.5 13.6 16.1 12.1 21.8
Very satisfied 45.2 41.1 33 39.4 43.9
Fairly satisfied 21.1 24.4 35.2 21.4 22.3
Partly satisfied to extremely
dissatisfied
10.1 20.9 15.8 27.1 12
Total 100 100 100 100 100 28.35***
(9)
Mastery
Low 17.4 37.6 41 74.4 22
Medium 46.9 47.7 38.3 20.3 46.1
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Good self-rated health was highly protective against
major depression (RRR 0.08, p < .001) and PMS plus
major depression (RRR 0.06, p < .001). Dissatisfaction at
work was a significant risk for PMS (RRR 2.42, p <
.001).
Discussion
Results of this population-based study showed that there
was a considerable percentage of women who reported
both moderate PMS and major depression (11% of
women with moderate PMS) or severe PMS and major
depression (25% of women with severe PMS). Women
with PMS and women with major depression differed
mainly in alcohol consumption, psychotropic drug con-
sumption, oral contraception and work dissatisfaction.
Factors that were related with a higher relative risk to
report both disorders were high psychological distress,
low mastery, psychotropic drug consumption, and low
self-rated health.
Differences in women with PMS and major depression
Women who reported using oral contraceptives were
more likely to suffer from major depression than the
reference group (women without major depression or
PMS). Although not significant, they were also less likely
to screen positive for PMS, which also has been found
in other studies [31]. These results reflect the controver-
sial and inconsistent results of studies on the effects of
oral contraceptives on mood disorders and PMS
[32-36]. In clinical practice, it seems therefore important
to be aware of a higher possibility of depression in
women who are using oral contraceptives and to con-
sider referring women with depressive symptoms taking
oral contraception for further assessment or treatment
to psychologists or psychiatrists. Work dissatisfaction
was a further factor that showed a differing risk in rela-
tion to PMS and major depression. High work dissatis-
faction was a specific risk for PMS. Kuczmierczyk et al.
[37] also found that women with PMS reported more
work pressure compared to women without PMS. The
results of this study do not allow concluding if PMS
influences work satisfaction or if certain strains at work
contribute to experiencing PMS symptoms. In patients
reporting work dissatisfaction PMS should be taken into
account as an associated factor. A higher consumption
of antidepressants in women with major depression was
expected. Alcohol was the fourth factor that
Table 3 Health status and health behavior in women without and with PMS, major depression, and with PMS plus
major depression (weighted prevalence rates) (Continued)
High 35.6 14.7 20.7 5.3 31.9
Total 100 100 100 100 100 104.00***
(6)
Physical activity
Inactive 11.3 16.6 12.5 8.1 11.9
Partially active 47.2 45.2 51 56.7 47.4
Active 41.5 38.2 36.5 35.2 40.7
Total 100 100 100 100 100 6.35 (6)
Self-rated health
Poor health 0.6 3.8 5.5 25.8 1.7
Fair health 4.8 8.6 13.6 22.8 6.1
Good health 94.6 87.6 80.9 51.4 92.2
Total 100 100 100 100 100 40.23***
(6)
Sleeping difficulties
Not at all 66.8 53.6 49.8 31.4 63.7
A bit 27.2 29 30.2 35.0 27.8
Strongly 6.0 17.4 20.0 33.6 8.6
Total 100 100 100 100 100 46.42***
(6)
Psychological distress
Low 84.2 66.0 55.2 34.3 79.6
Medium 12.9 23.8 30.1 32.2 15.4
High 2.9 10.3 14.7 33.5 4.9
Total 100 100 100 100 100 77.31***
(6)
*p < .05; **p < .01; ***p < .001
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Page 7 of 11Table 4 Relative risk ratios (95% confidence intervals) from multinominal logistic regression for women without
depression or PMS, women with PMS only, women with major depression only and women with PMS and major
depression (n = 2349)
No major depression
PMS
PMS Major
depression
PMS and major
depression
RRR (95% CI) RRR (95% CI) RRR (95% CI)
Age
14-24 1 1 1 1
25-34 1 1.14 (0.67-1.94) 1.30 (0.62-2.69) 1.22 (0.30-4.95)
35-44 1 1.35 (0.79-2.3) 1.06 (0.49-2.29) 0.52 (0.11-2.50)
45-54 1 1.04 (0.56-1.93) 0.96 (0.41-2.27) 0.92 (0.18-4.71)
Language regions
German-speaking 1 1 1 1
French-speaking 1 1.15 (0.86-1.55) 0.74 (0.49-1.12) 0.90 (0.40-2.03)
Italian-Speaking 1 1.84 (1.18-2.89)
**
0.43 (0.17-1.07) 0.76 (0.17-3.33)
Marital status
Unmarried 1 1 1 1
Married 1 0.72 (0.46-1.11) 1.38 (0.73-2.61) 1.08 (0.33-3.50)
Widowed 1 0.31 (0.04-2.40) 1.07 (0.13-9.02) + +
Separated/Divorced 1 0.90 (0.54-1.50) 1.26 (0.65-2.46) 2.00 (0.47-8.54)
Nationality
Swiss 1 1 1 1
Other 1 1.08 (0.73-1.62) 1.44 (0.84-2.48) 1.77 (0.68-4.61)
Education
Compulsory school 1 1 1 1
Secondary school 1 3.83 (1.36-10.83)
*
1.72 (0.62-4.74) 0.73 (0.17-3.06)
College/university 1 3.72 (1.30-10.68)
*
1.51 (0.53-4.30) 0.68 (0.15-3.20)
Living arrangements
Living alone 1 1 1 1
Couple without child 1 0.90 (0.57-1.44) 0.56 (0.30-1.06) 3.07 (0.86-10.97)
Couple with child 1 1.29 (0.81-2.04) 0.58 (0.30-1.12) 1.92 (0.49-7.51)
Single parent 1 0.96 (0.56-1.65) 1.20 (0.62-2.30) 0.85 (0.15-4.70)
Other 1 1.52 (0.53-4.33) + + 3.77 (0.31-45.4)
Pill as oral contraception
No 1 1 1 1
Yes 1 0.67 (0.44-1.00) 1.67 (1.03-2.72)* 1.10 (0.39-3.15)
Alcohol consumption
No consumption 1 1 1 1
Mild consumption 1 0.78 (0.58-1.04) 1.32 (0.84-2.06) 0.96 (0.41-2.27)
Moderate to severe consumption 1 0.34 (0.13-0.88)* 1.87 (0.79-4.44) 1.30 (0.22-7.51)
Psychotropic drug consumption
None 1 1 1 1
Antidepr. only 1 1.10 (0.43-2.79) 3.16 (1.40-7.13)** 5.38 (1.40-20.72)*
Tranquillizer/sleeping pills only 1 1.85 (0.95-3.59) 0.70 (0.24-2.06) 1.86 (0.40-8.62)
Tranquillizer/sleeping pills and
antidepressants
1 1.18 (0.34-4.10) 2.91 (0.95-8.90) 5.18 (1.13-23.84)*
Psychological distress
Low 1 1 1 1
Medium 1 1.23 (0.86-1.77) 1.68 (1.05-2.69)* 2.33 (0.89-6.10)
High 1 1.77 (0.97-3.23) 3.32 (1.67-6.57)** 7.97 (2.64-24.01)***
Mastery
Low 1 1 1 1
Medium 1 0.87 (0.63-1.19) 0.51 (0.33-0.79)** 0.42 (0.17-0.99)*
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Page 8 of 11differentiated between women with PMS and women
with major depression. Women with moderate to severe
alcohol consumption were less likely to report PMS.
Prevalence of both disorders
The prevalence of women who reported both disorders
was comparable with prevalence rates found by
Wittchen et al. [16], with slightly more than 20% of the
women reporting both disorders. Women who reported
suffering from severe PMS showed the highest percen-
tage of major depression, with a significant association
between severe PMS and major depression.
The results suggest that the group of women who suf-
fered from both PMS and major depression, were the
most impaired group, with women with high psycholo-
gical distress and consumption of antidepressants or a
combination of psychotropicd r u g sh a v i n gt h eh i g h e s t
risk to report both conditions. The high impairment
and high psychological distress suggests that for treat-
ment an interdisciplinary approach including psycholo-
gists or psychiatrists might be beneficial. Good self-rated
health and high mastery were protective factors against
both conditions (PMS and major depression together).
Soares et al. [29] found that women with PMDD and a
history of depression were less educated and reported
marital disruption less frequently than women with
PMDD and no history of depression. These results were
not confirmed in this study. Neither marital status nor
educational training was significantly associated with
both conditions being prevalent.
When considering the discussion about gender differ-
ences in depression, the findings about the association
between PMS and depression are also of significance. It
has been suggested that reproductive hormones might
contribute to the increased risk in women of suffering
from depression compared to men [38]. The relatively
high prevalence of women reporting both PMS and
major depression, as found in our study, sustains the
hypothesis of the contribution of reproductive hormones
and thus might be an explanatory factor for the higher
prevalence of depression in women compared to men.
Strengths and limitations
A limitation of our study is the cross-sectional design.
The results can therefore only be interpreted as associa-
tions. No causal relationships can be deduced and the
history of the development of symptoms is unclear. We
can therefore not distinguish if premenstrual symptoms
became more severe due to a major depression or if
depressive symptoms got worse due to premenstrual
symptoms. Furthermore, we used self-reporting mea-
sures which might result in an underreporting of the
proportion of women with major depression. Assuming
that women with major depression tend not to take part
in surveys and may be underrepresented in our sample,
the prevalence of major depression and of women
reporting both disorders may be lower in our study than
in the population. The associations between the predic-
tors and the groups may as a result be rather conserva-
tive. However, we do not expect a reporting bias
between the two affected groups given the observed pat-
tern of associations. The gold standard for the assess-
ment of PMS and PMDD is prospective daily rating.
The cross-sectional design and the used screening tools
did, however, not allow this procedure and the validity
of the diagnosis PMS in our study is therefore not
Table 4 Relative risk ratios (95% confidence intervals) from multinominal logistic regression for women without
depression or PMS, women with PMS only, women with major depression only and women with PMS and major
depression (n = 2349) (Continued)
High 1 0.39 (0.26-0.60)
***
0.34 (0.19-0.61)*** 0.15 (0.03-0.73)*
Self-rated health
Poor health 1 1 1 1
Fair health 1 0.81 (0.16-4.09) 0.16 (0.04-0.64)* 0.18 (0.03-1.05)
Good health 1 0.46 (0.10-2.16) 0.08 (0.02-0.28)*** 0.06 (0.01-0.33)**
Sleeping difficulties
Not at all 1 1 1 1
A bit 1 1.25 (0.93-1.69) 1.25 (0.82-1.89) 1.27 (0.54-2.99)
Strongly 1 1.03 (0.62-1.73) 1.41 (0.75-2.65) 0.68 (0.20-2.29)
Work satisfaction 1
Extremely satisfied 1 1 1 1
Very satisfied 1 1.19 (0.80-1.76) 0.84 (0.50-1.4) 0.78 (0.25-2.48)
Fairly satisfied 1 1.64 (1.07-2.51)* 1.38 (0.8-2.38) 0.67 (0.18-2.46)
Partly satisfied to extremely dissatisfied 1 2.42 (1.51-3.87)
***
1.05 (0.54-2.04) 1.70 (0.51-5.63)
+: Not enough cases in this category to analyze; *p < .05; **p < .01; ***p < .001
Forrester-Knauss et al. BMC Public Health 2011, 11:795
http://www.biomedcentral.com/1471-2458/11/795
Page 9 of 11entirely clear. For this reason, we did not to use the
term PMDD, but the terms moderate and severe PMS.
Furthermore, without prospective daily rating it is also
not clear whether some of the women reporting PMS
suffered from premenstrual exacerbation of major
depression and might therefore falsely be included in
the group of women with PMS. Strengths of our study
were the large population-based sample as well as the
use of two standardized screening tools in the Swiss
Health Survey allowing us to address their relationship
with additional indicators of health status and health
behaviour, and to control for confounds.
Conclusions
The results of this study suggest that for the group of
women who suffer from both major depression and PMS,
treatment might be particularly important and needed
given that they have been found to be more impaired
than women with one condition only. The risk for low
self-rated health was highest in women with both condi-
tions, which indicates that they are not only impaired on
a psychological level but also feel physically unwell. As
Breaux et al. [20] have stated in their review, more
research needs to be done on the comorbidity between
major depression and PMDD. The necessary differentia-
tion between the two disorders to assess comorbidity is
challenging and comorbidity might therefore not always
be detected and adequately treated in clinical practice.
However, results of this study suggest that it would be
important to do so, to be able to know more about their
co-occurrence and offer adequate treatment.
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